A Massachusetts judge is reducing the $39 million verdict awarded in September 2024 in a groundbreaking talc pleurodesis mesothelioma lawsuit. A significant portion of the original amount the jury ...
• Pleurodesis using talc or minocycline might be the treatment option against malignant pleural effusion (MPE) secondary to lung cancer with interstitial lung disease (ILD). What is known and what is ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results